Context And Aims: To describe current fluid and vasopressor practices after cardiac surgery in Australia and New Zealand cardiothoracic intensive care units (ICU).
Design And Setting: This web-based survey was conducted in cardiothoracic ICUs in Australia and New Zealand.
Methods: Intensivists, cardiac surgeons, and anesthetists were contacted to complete the online survey that asked questions regarding first and second choice fluids and vasopressors and the tools and factors that influenced these choices.
Objectives: To determine whether the early use of albumin after cardiac surgery in the first 24 hours in the intensive care unit (ICU) is associated with reduced mortality.
Design: A single-center nonrandomized retrospective cohort study using the Medical Information Mart in Intensive Care IV database.
Setting: A single cardiothoracic ICU in the United States during a period between 2008 to 2019.
Objectives: To investigate the effect of albumin exposure in ICU after cardiac surgery on hospital mortality, complications, and costs.
Design: A retrospective, single-center cohort study with economic evaluation.
Setting: Cardiothoracic ICU in Australia.
Interact Cardiovasc Thorac Surg
June 2010
The objective of this report is to share our experience with the different types of cardiac tumors, surgical management, postoperative complications and mid-term outcome of patients in an Australian tertiary hospital. Nineteen patients underwent cardiac surgery for tumors between 2001 and 2008. Their data was prospectively collected and retrospectively analyzed.
View Article and Find Full Text PDF